Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Board Changes

25 Aug 2016 07:00

RNS Number : 0802I
Phoenix Group Holdings
25 August 2016
 

 

Phoenix Group Holdings - Board Changes

 

The Board of Phoenix Group Holdings ("Phoenix") is pleased to announce the appointments of three new non-executive directors, Wendy Mayall, John Pollock and Nicholas Shott, all with effect from 1 September 2016.

 

Wendy Mayall has over thirty years' asset management experience, including as Group Chief Investment Officer and latterly consultant at Liverpool Victoria from 2012 to 2015, having previously been Chief Investment Officer for Unilever's UK pension fund from 1996 to 2011 and holding management responsibility for Unilever's pension funds globally. From 2006 to 2009, she was the Chair of the Investment Committee of the Mineworkers Pension Scheme, a British government appointment to one of the largest government backed pension schemes in the UK. Mrs Mayall is the non-executive Senior Independent Director of the Aberdeen UK Tracker Trust plc.

 

John Pollock had a highly successful career in life assurance at the Legal & General Group from 1980 to 2015, including as an executive director of Legal & General Group plc from 2003 to 2015. He held numerous senior roles, gaining wide strategic and technical experience, finally as Chief Executive Officer of LGAS (L&G Assurance Society), one of Legal and Generals' three primary business units, employing 6,000 staff. His previous roles included Chief Executive Officer (Protection and Annuities). Prior to his retirement from Legal and General in 2015, Mr Pollock held positions as Deputy Chair of the FCA Practitioner Panel, Chairman of investment platform Cofunds, and as a non-executive director of the Cala Homes Group.

 

Nicholas Shott is a highly experienced investment banker, who is European Vice Chairman of Lazard, a role he has held since 2007, and Head of UK Investment Banking at Lazard, which he has been since 2009. He joined Lazard in 1991 and became a partner in 1997. His wide experience of successfully advising clients on M&A deals in various sectors over many years is expected to be of significant benefit to Phoenix in pursuing its acquisition strategy.

 

The Phoenix Board also announces that Rene-Pierre Azria will be leaving the Board on 30 November 2016 after seven years as a non-executive director.

 

Commenting on the Board changes, Henry Staunton, Phoenix Chairman said: "I am delighted that we have secured the appointments to the Phoenix Board of three such experienced and successful individuals who will enhance the Board skillset in both quality and diversity. I would like to thank Rene-Pierre Azria for his valuable contribution to Phoenix since his appointment to the Board in September 2009 and through its progress as a premium listed company from July 2010. On behalf of all the Board, I wish him well."

 

No other information is required to be notified under Listing Rule 9.6.13 R.

 

Enquiries:

MediaNeil Bennett, MaitlandPeter Ogden, Maitland+ 44 (0) 20 7379 5151

InvestorsSam Perowne, Head of Investor Relations, Phoenix Group+44 (0) 203 735 0021

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPIMLTMBITBBF
Date   Source Headline
2nd May 201810:02 amRNSDirectorate Change
30th Apr 20184:15 pmRNSTotal Voting Rights
24th Apr 20183:45 pmRNSPublication of a Prospectus
19th Apr 201810:15 amRNSPre Stabilisation Notice
18th Apr 20184:34 pmRNSPublication of a Prospectus
13th Apr 20187:00 amRNSRestricted Tier 1 Roadshow Announcement
6th Apr 20184:00 pmRNSDirector/PDMR Shareholding
6th Apr 20184:00 pmRNSBlock listing Interim Review
29th Mar 20182:00 pmRNSTotal Voting Rights
27th Mar 20184:23 pmRNSNotice of AGM
22nd Mar 20184:10 pmRNSDirector/PDMR Shareholding
22nd Mar 20184:10 pmRNSDirector/PDMR Shareholding
21st Mar 20185:00 pmRNSDirector/PDMR Shareholding
21st Mar 20185:00 pmRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNSAnnual Financial Report
7th Mar 201810:30 amRNSDirector/PDMR Shareholding
28th Feb 201811:00 amRNSTotal Voting Rights
27th Feb 20182:30 pmRNSHolding(s) in Company
23rd Feb 20187:01 amRNSAcquisition of Standard Life Assurance
12th Feb 20189:00 amRNSHolding(s) in Company
12th Feb 20189:00 amRNSDirector/PDMR Shareholding
31st Jan 201811:45 amRNSTotal Voting Rights
30th Jan 20187:00 amRNSResidency Update
29th Dec 20171:00 pmRNSHolding(s) in Company
29th Dec 20171:00 pmRNSTotal Voting Rights
19th Dec 20175:00 pmRNSHolding(s) in Company
6th Dec 20174:30 pmRNSDirector/PDMR Shareholding
4th Dec 20174:00 pmRNSDirector Declaration
30th Nov 20174:00 pmRNSTotal Voting Rights
28th Nov 20174:30 pmRNSHolding(s) in Company
8th Nov 20175:20 pmRNSDirector/PDMR Shareholding
3rd Nov 201712:45 pmRNSHolding(s) in Company
31st Oct 20173:00 pmRNSTotal Voting Rights
27th Oct 20174:30 pmRNSHolding(s) in Company
27th Oct 20174:30 pmRNSHolding(s) in Company
20th Oct 20174:30 pmRNSHolding(s) in Company
18th Oct 20174:45 pmRNSHolding(s) in Company
16th Oct 20174:30 pmRNSHolding(s) in Company
13th Oct 20174:15 pmRNSHolding(s) in Company
9th Oct 20174:00 pmRNSBlock listing Interim Review
6th Oct 20174:00 pmRNSDirector/PDMR Shareholding
4th Oct 20174:45 pmRNSDirector/PDMR Shareholding
29th Sep 20173:00 pmRNSTotal Voting Rights
13th Sep 20174:30 pmRNSPublication of Suppl.Prospcts
12th Sep 20179:15 amRNSHolding(s) in Company
12th Sep 20179:15 amRNSHolding(s) in Company
7th Sep 20173:30 pmRNSDirector/PDMR Shareholding
31st Aug 20174:45 pmRNSTotal Voting Rights
31st Aug 20174:45 pmRNSHolding(s) in Company
24th Aug 20177:00 amRNS2017 Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.